Overview of Investment Fund Collaboration - The company, Beijing Zhaoyan New Drug Research Center Co., Ltd., has approved an investment of up to 20 million RMB to participate in the establishment of the Huaxia Zhiyuan Venture Capital Fund [2][3] - The fund aims to engage in investment activities primarily in unlisted companies within the full industry chain of molecular diagnostics and targeted therapies [4][5] Partnership Agreement Details - A partnership agreement has been signed with Huaxia Equity Investment Fund Management (Beijing) Co., Ltd., which will act as the general partner and fund manager [2][4] - The partnership has a term of 20 years, with an investment operation period of 7 years, extendable by up to 2 years under certain conditions [3][4] Fund Structure and Financials - The target total subscription amount for the fund is 35 million RMB, with a minimum contribution of 10 million RMB for each limited partner [3][5] - The management fee is set at 1% per year of the total paid-in capital, calculated daily [5] Investment Focus - The fund will focus on investments in the full industry chain of biomedicine for molecular diagnostics and targeted therapies, particularly in the development of Alpha-targeted therapies [4][5]